Otsuka 

$20.77
14
+$0.00+0% Monday 13:30

Statistics

Day High
20.77
Day Low
20.77
52W High
23.04
52W Low
19
Volume
1,000
Avg. Volume
-
Mkt Cap
7.89B
P/E Ratio
26.69
Dividend Yield
1.49%
Dividend
0.31

Upcoming

Dividends

1.49%Dividend Yield
Mar 26
$0.29
Sep 25
$0.31
Mar 25
$0.03
Mar 25
$0.48
Mar 24
$0.48
10Y Growth
5.62%
5Y Growth
10.56%
3Y Growth
12.07%
1Y Growth
5.56%

Earnings

3AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.19
0.25
0.3
0.35
Expected EPS
0.25425177074320005
Actual EPS
N/A

Financials

4.81%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
14.61BRevenue
702.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OSUKF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap332.67B
Roche operates in similar pharmaceutical and diagnostics segments, competing directly in the development of innovative drugs and health solutions.
Pfizer
PFE
Mkt Cap149.38B
Pfizer competes in the pharmaceutical sector, offering a wide range of products that overlap with Otsuka's portfolio, including mental health medications.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson's broad healthcare portfolio, including pharmaceuticals and medical devices, positions it as a competitor across several of Otsuka's business areas.
Novartis
NVS
Mkt Cap292.07B
Novartis competes in pharmaceuticals and healthcare, offering products in areas like neurology and psychiatry, directly competing with Otsuka's offerings.
Merck
MRK
Mkt Cap294.03B
Merck operates in the pharmaceutical industry, competing with Otsuka in areas such as healthcare solutions and drug development.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, with its strong presence in the pharmaceuticals sector, competes in areas of mutual interest like neuroscience and oncology.
Takeda Pharmaceutical
TAK
Mkt Cap50.27B
Takeda Pharmaceutical Company has a significant overlap with Otsuka in the pharmaceutical sector, especially in Japan, competing in similar therapeutic areas.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline competes with Otsuka in the pharmaceutical and healthcare sectors, including areas like mental health.
Sanofi
SNY
Mkt Cap105.92B
Sanofi operates globally in the pharmaceutical sector, competing with Otsuka in various therapeutic areas, including mental health and neurology.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca is a global competitor in the pharmaceutical industry, with a product range that competes with Otsuka's, especially in the oncology and neurology segments.

About

Otsuka Corporation, headquartered in Tokyo, Japan, operates as a technology services provider, primarily focusing on system integration and comprehensive support solutions within Japan. Its System Integration Business segment delivers a wide array of services, including strategic consulting, system design and development, transport and installation, and network infrastructure construction. This division also furnishes clients with vital management systems and collaborative software, such as enterprise resource planning (ERP) systems and groupware, tailored for specialized areas like CAD and web technologies. Additionally, it supplies a full suite of software, hardware, intranet, and security products essential for establishing and expanding computer networks. The segment is also involved in the sale of computers, copiers, communication equipment, and associated software, alongside undertaking custom software development projects. The Service and Support Business segment is dedicated to providing critical post-implementation assistance. This encompasses supplying consumables, performing hardware and software maintenance, offering dedicated telephone support, and managing various outsourcing requirements. A key offering is their emergency computer rescue service, available to both corporate entities and individual users. Furthermore, this segment delivers extensive network support, covering the entire lifecycle of corporate information systems from initial planning and design to construction and ongoing operation. It also provides expert system engineers on an outsourced basis and offers educational support services. Otsuka Corporation was established in 1961.
Show more...
CEO
Mr. Yuji Otsuka
Employees
9680
Country
United States
ISIN
JP3188200004

Listings

0 Comments

Share your thoughts

FAQ

What is Otsuka stock price today?
The current price of OSUKF is $20.77 USD — it has increased by +0% in the past 24 hours. Watch Otsuka stock price performance more closely on the chart.
What is Otsuka stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Otsuka stocks are traded under the ticker OSUKF.
What is Otsuka market cap?
Today Otsuka has the market capitalization of 7.89B
When is the next Otsuka earnings date?
Otsuka is going to release the next earnings report on August 03, 2026.
What were Otsuka earnings last quarter?
OSUKF earnings for the last quarter are 0.28 USD per share, whereas the estimation was 0.25 USD resulting in a +9.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Otsuka revenue for the last year?
Otsuka revenue for the last year amounts to 14.61B USD.
What is Otsuka net income for the last year?
OSUKF net income for the last year is 702.99M USD.
Does Otsuka pay dividends?
Yes, OSUKF dividends are paid semi-annual. The last dividend per share was 0.29 USD. As of today, Dividend Yield (FWD)% is 1.49%.
How many employees does Otsuka have?
As of June 22, 2026, the company has 9,680 employees.
In which sector is Otsuka located?
Otsuka operates in the Technology sector.
When did Otsuka complete a stock split?
The last stock split for Otsuka was on March 28, 2024 with a ratio of 2:1.
Where is Otsuka headquartered?
Otsuka is headquartered in Tokyo, United States.